Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tumor antigen LRRC15 impedes adenoviral infection: implications for virus-based cancer therapy.

Tumor antigen LRRC15 impedes adenoviral infection: implications for virus-based cancer therapy. J Virol. 2008 Jun; 82(12):5933-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.